Affimed NV (AFMD)
5.16
+0.09
(+1.78%)
USD |
NASDAQ |
Apr 19, 16:00
5.20
+0.04
(+0.78%)
After-Hours: 20:00
Affimed Total Liabilities (Quarterly): 43.50M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 43.50M |
| September 30, 2023 | 46.62M |
| June 30, 2023 | 38.89M |
| March 31, 2023 | 46.74M |
| December 31, 2022 | 51.04M |
| September 30, 2022 | 54.35M |
| June 30, 2022 | 71.12M |
| March 31, 2022 | 84.64M |
| December 31, 2021 | 100.98M |
| September 30, 2021 | 100.31M |
| June 30, 2021 | 115.60M |
| March 31, 2021 | 119.28M |
| December 31, 2020 | 127.59M |
| September 30, 2020 | 71.53M |
| June 30, 2020 | 68.21M |
| March 31, 2020 | 72.61M |
| December 31, 2019 | 82.55M |
| September 30, 2019 | 69.28M |
| June 30, 2019 | 75.35M |
| March 31, 2019 | 76.01M |
| December 31, 2018 | 86.99M |
| Date | Value |
|---|---|
| September 30, 2018 | 15.36M |
| June 30, 2018 | 14.26M |
| March 31, 2018 | 15.20M |
| December 31, 2017 | 13.89M |
| September 30, 2017 | 13.61M |
| June 30, 2017 | 14.97M |
| March 31, 2017 | 10.10M |
| December 31, 2016 | 10.56M |
| September 30, 2016 | 11.26M |
| June 30, 2016 | 10.10M |
| March 31, 2016 | 12.29M |
| December 31, 2015 | 13.17M |
| September 30, 2015 | 10.59M |
| June 30, 2015 | 10.62M |
| March 31, 2015 | 9.353M |
| December 31, 2014 | 12.30M |
| September 30, 2014 | 12.79M |
| June 30, 2014 | 144.65M |
| March 31, 2014 | 167.67M |
| December 31, 2013 | 145.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
38.89M
Minimum
Jun 2023
127.59M
Maximum
Dec 2020
75.80M
Average
71.53M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| InflaRx NV | 19.48M |
| MorphoSys AG | 2.186B |
| BioNTech SE | 3.051B |
| Immatics NV | 314.91M |
| CureVac NV | 254.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.40M |
| Shareholders Equity (Quarterly) | 63.90M |
| Debt to Equity Ratio | 0.2102 |
| Current Ratio | 3.250 |
| Net Debt Paydown Yield | 0.91% |